Relating to the establishment of a consortium to conduct United States Food and Drug Administration's drug development clinical trials with ibogaine to secure the administration's approval of the medication's use for treatment of opioid use disorder, co-occurring substance use disorder, and any other neurological or mental health conditions for which ibogaine demonstrates efficacy and to the administration of that treatment.

Looking ahead

No hearings or votes scheduled.

History

1. 2025
   1. Jun 11Effective immediatelyLatest
   2. Jun 11Signed by the Governor Greg AbbottBecame Law
   3. Jun 3Sent to the GovernorTo Governor
   4. Jun 2Signed in the HouseMajor
   5. Jun 2Signed in the SenateMajor
   6. Jun 2Reported enrolledMinor
   7. Jun 1House adopts conf. comm. report-reported
      • Vote recorded passage. Result: pass.Upper
      • Vote recorded passage. Result: pass.Lower
   8. Jun 1Statement(s) of vote recorded in Journal
   9. Jun 1Record vote
   10. Jun 1House adopts conference committee reportMinor
   11. Jun 1House adopts resolution to go outside bounds
   12. May 31Senate adopts conf. comm. report-reported
       • Vote recorded passage. Result: pass.Upper
   13. May 31Record vote
   14. May 31Senate adopts conference committee reportMinor
   15. May 31Senate adopts resolution to go outside bounds
   16. May 30Conf. Comm. Report distributed
   17. May 30Conference committee report filedMinor
   18. May 21House appoints conferees-reported
   19. May 21House grants request for conf comm-reported
   20. May 20House appoints conferees
   21. May 20House grants request for conference committee
   22. May 15Senate appoints conferees-reported
   23. May 15Senate requests conference committee-reported
   24. May 15Senate refuses to concur-reported
   25. May 15Senate appoints conferees
   26. May 15Senate requests conference committee
   27. May 15Senate refuses to concur
   28. May 15Read
   29. May 15House amendment(s) laid before the Senate
   30. May 14House passage as amended reportedMajor
   31. May 13Statement(s) of vote recorded in Journal
       • Vote recorded passage. Result: pass.Lower
   32. May 13Record vote
   33. May 13PassedPassed House
   34. May 13Read 3rd timeMinor
   35. May 12Statement(s) of vote recorded in Journal
       • Vote recorded passage. Result: pass.Lower
   36. May 12Record vote
   37. May 12Passed to 3rd reading as amendedMajor
   38. May 12AmendedMajor
   39. May 12Read 2nd timeMinor
   40. May 12Laid out in lieu of companion
   41. May 12Committee report sent to Calendars
   42. May 12Committee report distributed
   43. May 12Comte report filed with Committee CoordinatorMinor
   44. May 8Reported favorably as substitutedMinor
   45. May 8Committee substitute considered in committeeMajor
   46. May 8Considered in formal meeting
   47. May 2Referred to Public HealthMinor
   48. May 2Read first timeMinor
   49. May 1Received from the SenateMinor
   50. Apr 30Reported engrossed
       • Vote recorded passage. Result: pass.Upper
       • Vote recorded Senate Rule 7.18 and the Constitutional Rule requiring bills to be read on three several days be suspended and that SB 2308 be placed on its third reading and final passage. Result: pass.Upper
   51. Apr 30Record vote
   52. Apr 30PassedPassed Senate
   53. Apr 30Read 3rd timeMinor
   54. Apr 30Record vote
   55. Apr 30Three day rule suspended
   56. Apr 30Record vote
   57. Apr 30Read 2nd time & passed to engrossmentMinor
   58. Apr 30Record vote
   59. Apr 30Rules suspended-Regular order of business
   60. Apr 29Placed on intent calendar
   61. Apr 29Co-author authorized
   62. Apr 28Committee report printed and distributed
   63. Apr 28Reported favorably w/o amendmentsMinor
   64. Apr 24Vote taken in committee
   65. Apr 24Considered in public hearing
   66. Apr 23Left pending in committee
   67. Apr 23Testimony taken in committee
   68. Apr 23Considered in public hearing
   69. Apr 23Scheduled for public hearing on . . .
   70. Mar 25Referred to Health & Human ServicesMinor
   71. Mar 25Read first timeMinor
   72. Mar 11FiledMinor
   73. Mar 11Received by the Secretary of the SenateIntroduced